6-K//Foreign company update
Enlivex Therapeutics Ltd. 6-K
Accession 0001213900-25-110920
$ENLVCIK 0001596812other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:30 PM ET
Size
408.9 KB
Accession
0001213900-25-110920
Documents
- 6-Kea0265573-6k_enlivex.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
- EX-99.1ea026557301ex99-1_enlivex.htm
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR ENLIVEX AS OF SEPTEMBER 30, 2025 AND DECEMBER 31, 2024 AND FOR THE THREE AND NINE MONTH PERIODS ENDED SEPTEMBER 30, 2025 AND 2024
- EX-99.2ea026557301ex99-2_enlivex.htm
OPERATING AND FINANCIAL REVIEW AND PROSPECTS AS OF AND FOR THE THREE AND NINE MONTH PERIODS ENDED SEPTEMBER 30, 2025 AND 2024
Issuer
Enlivex Therapeutics Ltd.
CIK 0001596812
Entity typeother
IncorporatedIsrael
Related Parties
1- filerCIK 0001596812
Filing Metadata
- Form type
- 6-K
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:30 PM ET
- Size
- 408.9 KB